MedTrace Logo

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

NCT05911711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-06-22

No results posted yet for this study

Summary

Sepsis, a severe response to bacterial infection, lacks understanding of immunometabolic features that can identify high-risk patients. This study aimed to discover immune, biological, and metabolic biomarkers in sepsis patients with poor prognosis and understand the underlying mechanisms of host immune responses.

Conditions

Interventions

OTHER

Prognostic factor

normal person (no sepsis group)

Sponsors & Collaborators

  • Chungnam National University

    collaborator OTHER

  • Chungnam National University Hospital

    collaborator OTHER

  • Kangdong Sacred Heart Hospital

    lead OTHER

Principal Investigators

  • So Young Park, doctor · Kangdong Sacred Heart Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-07
Primary Completion
2023-12-31
Completion
2024-06-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911711 on ClinicalTrials.gov